Generics - Erbitux

Filter

Current filters:

Erbitux

Popular Filters

151 to 175 of 1254 results

AstraZeneca’s patent protection for Pulmicort Respules upheld by US court

AstraZeneca’s patent protection for Pulmicort Respules upheld by US court

31-10-2013

The US Court of Appeals for the Federal Circuit has reversed and remanded for further proceedings a trial…

AstraZenecaGenericsLegalNorth AmericaPulmicort Respules

Brazilian pharmachemical sector discussed at parliamentary public hearing

31-10-2013

Fiocruz's Production and Innovation in Health vice-president Jorge Bermudez highlighted the importance…

FinancialGenericsProductionSouth America

Teva Pharmaceutical says CEO Jeremy Levin has resigned

Teva Pharmaceutical says CEO Jeremy Levin has resigned

30-10-2013

Israel-based Teva Pharmaceutical Industries, say that, despite its recent denials of a rift with its…

BoardroomGenericsManagementTeva Pharmaceutical Industries

“Generics, Get the Facts Straight” - subject of South Africa workshop

“Generics, Get the Facts Straight” - subject of South Africa workshop

29-10-2013

South Africa’s National Association of Pharmaceutical Manufacturers (NAPM) held a workshop for health…

GenericsPricingRegulationRest of the WorldSouth Africa

Bumper 3rd-qtr for Actavis, with 57% net revenue leap

Bumper 3rd-qtr for Actavis, with 57% net revenue leap

29-10-2013

US generics major Actavis has reported a net revenue increase of 57% to $2.01 billion for the third quarter…

ActavisFinancialGenerics

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

European generic drugmakers call for maintenance of current robust WHO INN system

24-10-2013

The World Health Organization Consultation on International Non-proprietary Names (INN), open session…

BiosimilarsEuropeGenericsRegulation

Rise or demise of Japan’s generics by P Reed Maurer

Rise or demise of Japan’s generics by P Reed Maurer

16-10-2013

Generics in Japan are a work in progress. Presently they account for about 28% of pharmaceutical volume,…

Asia-PacificGenericsMarkets & MarketingPricing

Dramatic increase in use of generic drugs in Japan confirmed

Dramatic increase in use of generic drugs in Japan confirmed

15-10-2013

A subcommittee of Japan’s Central Social Insurance Medical Council looked at the effect of the April…

Asia-PacificGenericsMarkets & MarketingRegulation

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI

14-10-2013

Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

EGA views future for generics and biosimilars in Europe

EGA views future for generics and biosimilars in Europe

14-10-2013

The European Generic medicines Association (EGA) recently launched its industrial policy vision for the…

BiosimilarsEuropeGenericsMarkets & MarketingRegulation

Akorn buy of Hi-Tech Pharmacal delayed by FTC request

13-10-2013

In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Acura Pharma settles with Par and Impax over Oxecta

Acura Pharma settles with Par and Impax over Oxecta

11-10-2013

US specialty pharma firm Acura Pharmaceuticals saw its shares leap as much as 28% after it said that…

Acura PharmaceuticalsGenericsImpax LaboratoriesLicensingNeurologicalNorth AmericaOxectaPar PharmaceuticalPatents

Increase in chronic and lifestyle-associated diseases to Brazil market sales

Increase in chronic and lifestyle-associated diseases to Brazil market sales

11-10-2013

Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma…

GenericsPharmaceuticalSouth America

Teva to cut 5,000 jobs as it accelerates cost savings plan

Teva to cut 5,000 jobs as it accelerates cost savings plan

10-10-2013

Israel-based Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it is taking…

FinancialGenericsManagement

Actavis confirms generic Suboxone sublingual film patent challenge

Actavis confirms generic Suboxone sublingual film patent challenge

09-10-2013

Actavis has filed an Abbreviated New Drug Application with the US Food and Drug Administration for buprenorphine…

ActavisGenericsNeurologicalNorth AmericaPatentsReckitt BenckiserSuboxone

Epic Pharma gets rights to sell 12 generics

08-10-2013

Elite Pharmaceuticals (OTCBB: ELTP) has signed a manufacturing and license agreement with fellow USA-based,…

Epic PharmaGenericsLicensingNorth AmericaProduction

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands

04-10-2013

The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…

EuropeGenericsLegalNeurologicalPatentsPharmaceutical

Modest growth forecast for Greek pharma market, despite unstable economy

04-10-2013

The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek…

EuropeGenericsHealthcareMarkets & MarketingPharmaceuticalPricing

Increased use of generic drugs in South Africa could save health sector 400 million rand

Increased use of generic drugs in South Africa could save health sector 400 million rand

02-10-2013

In South Africa, a switch of 5% of the volume of branded medicines to a generic equivalent could save…

FinancialGenericsHealthcareMarkets & MarketingRest of the WorldSouth Africa

Kissei and JCR conclude accord on biosimilar Aranesp

01-10-2013

Kissei Pharmaceutical and JCR Pharmaceuticals have announced the conclusion of a collaborative R&D agreement…

AmgenAranespAsia-PacificBiosimilarsGenericsJCR PharmaceuticalsKissei PharmaceuticalOncologyResearch

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal

30-09-2013

Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

Highlights from European Cancer Congress on Kadcyla, Yervoy, Erbitux and Somatuline

30-09-2013

A host of new oncology data was presented at the European Cancer Congress in Amsterdam, the Netherlands,…

Bristol-Myers SquibbErbituxEuropeIpsenKadcylaMerck KGaAOncologyPharmaceuticalResearchRocheSomatulineYervoy

151 to 175 of 1254 results

Back to top